Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Abel

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|January 24, 1975
Evolution of the Nation's Ocean ProgramR B Abel
Journal of Clinical Pharmacology|April 1, 1997
Rate of low-density lipoprotein cholesterol and apolipoprotein B changes on initiation and discontinuation of atorvastatin treatmentR H Stern, R B Abel
Journal of the American Podiatry Association|April 1, 1976
The incidence of isolation of Candida species from the human footR B Abel, J S Becker, R Green, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 4, 1998
Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assayW W Bullen, C D Lathia, R B Abel, et al.
Epilepsia|April 29, 1999
Effects of age and gender on single-dose pharmacokinetics of gabapentinR A Boyd, D Türck, R B Abel, et al.
Journal of Clinical Pharmacology|July 1, 1996
Pharmacokinetic and pharmacodynamic comparisons of twice daily and four times daily formulations of procainamide in patients with frequent ventricular premature depolarizationB B Yang, R B Abel, A C Uprichard, et al.
Therapeutic Drug Monitoring|March 5, 1998
Effect of age, gender, and race on steady state procainamide pharmacokinetics after administration of procanbid sustained-release tabletsJ R Koup, R B Abel, J A Smithers, et al.
Journal of Clinical Pharmacology|April 29, 1998
Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatinR H Stern, B B Yang, M Horton, et al.
Journal of Clinical Pharmacology|June 27, 2000
Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitorR H Stern, B B Yang, N J Hounslow, et al.
Journal of Clinical Pharmacology|November 1, 1996
Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estroneR A Boyd, B B Yang, R B Abel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|January 24, 1975
Evolution of the Nation's Ocean ProgramR B Abel
Journal of Clinical Pharmacology|April 1, 1997
Rate of low-density lipoprotein cholesterol and apolipoprotein B changes on initiation and discontinuation of atorvastatin treatmentR H Stern, R B Abel
Journal of the American Podiatry Association|April 1, 1976
The incidence of isolation of Candida species from the human footR B Abel, J S Becker, R Green, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 4, 1998
Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assayW W Bullen, C D Lathia, R B Abel, et al.
Epilepsia|April 29, 1999
Effects of age and gender on single-dose pharmacokinetics of gabapentinR A Boyd, D Türck, R B Abel, et al.
Journal of Clinical Pharmacology|July 1, 1996
Pharmacokinetic and pharmacodynamic comparisons of twice daily and four times daily formulations of procainamide in patients with frequent ventricular premature depolarizationB B Yang, R B Abel, A C Uprichard, et al.
Therapeutic Drug Monitoring|March 5, 1998
Effect of age, gender, and race on steady state procainamide pharmacokinetics after administration of procanbid sustained-release tabletsJ R Koup, R B Abel, J A Smithers, et al.
Journal of Clinical Pharmacology|April 29, 1998
Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatinR H Stern, B B Yang, M Horton, et al.
Journal of Clinical Pharmacology|June 27, 2000
Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitorR H Stern, B B Yang, N J Hounslow, et al.
Journal of Clinical Pharmacology|November 1, 1996
Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estroneR A Boyd, B B Yang, R B Abel, et al.
Pageof 2